federal_register: 02-32440
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02-32440 | Oral Dosage Form New Animal Drugs; Clindamycin Liquid; Change of Sponsor's Address | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Delmarva Laboratories, Inc., and a change of this sponsor's address. The ANADA provides for oral use of clindamycin hydrochloride liquid in dogs and cats for the treatment of various bacterial infections. | 2002-12-26 | 2002 | 12 | https://www.federalregister.gov/documents/2002/12/26/02-32440/oral-dosage-form-new-animal-drugs-clindamycin-liquid-change-of-sponsors-address | https://www.govinfo.gov/content/pkg/FR-2002-12-26/pdf/02-32440.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Delmarva Laboratories, Inc., and a change of this sponsor's address. The ANADA provides... |